Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

31.03.2025

1 Ann Intern Med
1 BMJ
1 Clin Infect Dis
1 Emerg Infect Dis
1 Intensive Care Med
3 J Infect
2 J Med Virol
6 J Virol
1 JAMA
1 Nat Ment Health
4 Nature
1 Science
2 Travel Med Infect Dis



    Ann Intern Med

  1. GRANWEHR BP
    CBT and rehabilitation improved long COVID symptoms.
    Ann Intern Med. 2025;178:JC28.
    >> Share


    BMJ

  2. WISE J
    Covid-19: Inquiry hears of doctors' lack of confidence in PPE as ministers defend VIP lane.
    BMJ. 2025;388:r584.
    >> Share


    Clin Infect Dis

  3. ALLAN-BLITZ LT, Klausner JD
    Shifting the Focus in Acute SARS-CoV-2 Management to Include Prevention of Long-COVID.
    Clin Infect Dis. 2025 Mar 26:ciaf158. doi: 10.1093.
    >> Share


    Emerg Infect Dis

  4. SANDER B, Mishra S, Swayze S, Sahakyan Y, et al
    Population-Based Matched Cohort Study of COVID-19 Healthcare Costs, Ontario, Canada.
    Emerg Infect Dis. 2025;31:710-719.
    >> Share


    Intensive Care Med

  5. BIHLMAIER K, Willam C, Herbst L, Hackstein H, et al
    Rapid clinical effects of convalescent plasma therapy in severe COVID-19 acute respiratory distress syndrome (ARDS).
    Intensive Care Med. 2025 Mar 26. doi: 10.1007/s00134-025-07863.
    >> Share


    J Infect

  6. JIN R, Qin T, Li P, Yuan J, et al
    Increased Circulation of Adenovirus in China During 2023-2024: Association with an Increased Prevalence of Species B and School-Associated Transmission.
    J Infect. 2025 Mar 21:106475. doi: 10.1016/j.jinf.2025.106475.
    >> Share

  7. CARSTENS G, Kozanli E, Bulsink K, McDonald S, et al
    Co-infection dynamics of SARS-CoV-2 and respiratory viruses in the 2022/2023 respiratory season in the Netherlands.
    J Infect. 2025 Mar 21:106474. doi: 10.1016/j.jinf.2025.106474.
    >> Share

  8. BING J, Huang Y, Du H, Guo P, et al
    Rapid spread of Candida auris in China after COVID-19.
    J Infect. 2025 Mar 21:106476. doi: 10.1016/j.jinf.2025.106476.
    >> Share


    J Med Virol

  9. LARSEN TG, Ginty JR, Jessen R, Nielsen RB, et al
    Virus Monitoring in Denmark: A Community-Based Self-Sampling System to Surveil Respiratory Viruses and Associated Symptoms.
    J Med Virol. 2025;97:e70293.
    >> Share

  10. TACHIKAWA J, Aizawa Y, Watanabe K, Haino K, et al
    Sustained Maternal Antibodies Against Parechovirus-A3 During the Coronavirus Disease 2019 Pandemic.
    J Med Virol. 2025;97:e70313.
    >> Share


    J Virol

  11. NOETTGER S, Zech F, Nchioua R, Pastorio C, et al
    Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.
    J Virol. 2025 Mar 28:e0220224. doi: 10.1128/jvi.02202.
    >> Share

  12. JANA ID, Kanjo K, Roy S, Bhasin M, et al
    Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants.
    J Virol. 2025 Mar 26:e0005125. doi: 10.1128/jvi.00051.
    >> Share

  13. ZHANG S, Cao Y, Huang Y, Zhang X, et al
    Abortive PDCoV infection triggers Wnt/beta-catenin pathway activation, enhancing intestinal stem cell self-renewal and promoting chicken resistance.
    J Virol. 2025 Mar 26:e0013725. doi: 10.1128/jvi.00137.
    >> Share

  14. LI P, Faraone JN, Hsu CC, Chamblee M, et al
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.
    J Virol. 2025 Mar 26:e0024225. doi: 10.1128/jvi.00242.
    >> Share

  15. JOHN K, Huntress I, Smith E, Chou H, et al
    Human long noncoding RNA VILMIR is induced by major respiratory viral infections and modulates the host interferon response.
    J Virol. 2025 Mar 25:e0014125. doi: 10.1128/jvi.00141.
    >> Share

  16. DADONAITE B, Burrell AR, Logue J, Chu HY, et al
    SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.
    J Virol. 2025 Mar 25:e0010925. doi: 10.1128/jvi.00109.
    >> Share


    JAMA

  17. HANLON P, Butterly E, Wei L, Wightman H, et al
    Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
    JAMA. 2025 Feb 3:e2427402. doi: 10.1001/jama.2024.27402.
    >> Share


    Nat Ment Health

  18. ATLAS LY, Farmer C, Shaw JS, Gibbons A, et al
    Dynamic effects of psychiatric vulnerability, loneliness and isolation on distress during the first year of the COVID-19 pandemic.
    Nat Ment Health. 2025;3:199-211.
    >> Share


    Nature

  19. KOZLOV M
    Exclusive: NIH to cut grants for COVID research, documents reveal.
    Nature. 2025 Mar 26. doi: 10.1038/d41586-025-00954.
    >> Share

  20. VAN DAMME E, Abeywickrema P, Yin Y, Xie J, et al
    A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.
    Nature. 2025 Mar 26. doi: 10.1038/s41586-025-08651.
    >> Share

  21. WANG X, Huang Z, Xing L, Shang L, et al
    STING agonist-based ER-targeting molecules boost antigen cross-presentation.
    Nature. 2025 Mar 26. doi: 10.1038/s41586-025-08758.
    >> Share

  22. LAPORTE M, Jochmans D, Bardiot D, Desmarets L, et al
    A coronavirus assembly inhibitor that targets the viral membrane protein.
    Nature. 2025 Mar 26. doi: 10.1038/s41586-025-08773.
    >> Share


    Science

  23. COHEN J
    U.S. cuts hamper disease surveillance worldwide.
    Science. 2025;387:1336-1337.
    >> Share


    Travel Med Infect Dis

  24. PFAAR H, Lopez-Medina E, Escudero I, Hutagalung Y, et al
    Operational challenges and lessons learned from conducting febrile surveillance in a long-term randomized dengue vaccine trial in Latin America and Asia-Pacific.
    Travel Med Infect Dis. 2025 Mar 20:102840. doi: 10.1016/j.tmaid.2025.102840.
    >> Share

  25. BOGACKA A, Wroczynska A, Grzybek M
    Polish travellers on the move: a study of knowledge of travel health and associated practices among Polish travellers abroad.
    Travel Med Infect Dis. 2025 Mar 20:102842. doi: 10.1016/j.tmaid.2025.102842.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016